Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
RESPONSIBILITIES Plan, execute and analyze in vivo pharmacology studies. Characterize new in vivo mouse models, including syngeneic genetically engineered and orthotopic mouse models to study biologic mechanisms and
-
innovation and broad-based access to quality medicines and products. The DCP Development Engineering team is responsible for the new product development and engineering for a variety of medical device and
-
/volunteers arrive for visits, check-ins, and discharges late. Be able to function autonomously. Perform critical problem solving BASIC QUALIFICATIONS An Associate's degree in Medical Technology is required
-
(s), as appropriate, in close collaboration with Corporate Affairs and HQ Medical Affairs. Deliver insights on local patient organization structure, capabilities, and patient population needs. Serve
-
collaboration with Corporate Affairs and HQ Medical Affairs. Deliver insights on local patient organization structure, capabilities, and patient population needs. Serve on Medical and/or TA and asset cross
-
Engineering to ensure the data ecosystem is conducive for data science modeling purposes. Partner with Digital teams to enhance data science capabilities, aligning efforts to leverage digital data sources
-
functional leads for Insight and Strategy, Analytics Engineering, Market Research, Analytics Governance to develop and implement models, insights, and data products that drive brands' strategic priorities. You
-
intelligence to aid in experiment design. These goals will be achieved through partnership with other disciplines including data scientists, analytical chemists, engineers, and process chemists to develop
-
Medical Affairs. Deliver insights on local patient organization structure, capabilities, and patient population needs. Serve on M edical and/or TA and asset cross-functional committees, as appropriate
-
Medical Affairs. Deliver insights on local patient organization structure, capabilities, and patient population needs. Serve on M edical and/or TA and asset cross-functional committees, as appropriate